Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

The GBA p.Trp378Gly mutation is a probable French-Canadian founder mutation causing Gaucher disease and synucleinopathies.

Ruskey JA, Zhou S, Santiago R, Franche LA, Alam A, Roncière L, Spiegelman D, Fon EA, Trempe JF, Kalia LV, Postuma RB, Dupre N, Rivard GE, Assouline S, Amato D, Gan-Or Z.

Clin Genet. 2018 Jun 19. doi: 10.1111/cge.13405. [Epub ahead of print]

PMID:
29920646
2.

Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder.

Li J, Ruskey JA, Arnulf I, Dauvilliers Y, Hu MTM, Högl B, Leblond CS, Zhou S, Ambalavanan A, Ross JP, Bourassa CV, Spiegelman D, Laurent SB, Stefani A, Charley Monaca C, Cochen De Cock V, Boivin M, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Labbe C, Ferman TJ, Dion PA, Fan D, Desautels A, Gagnon JF, Dupré N, Fon EA, Montplaisir JY, Boeve BF, Postuma RB, Rouleau GA, Ross OA, Gan-Or Z.

Mov Disord. 2018 May 14. doi: 10.1002/mds.27385. [Epub ahead of print]

PMID:
29756641
3.

Longstanding disease-free survival in idiopathic REM sleep behavior disorder: Is neurodegeneration inevitable?

Yao C, Fereshtehnejad SM, Dawson BK, Pelletier A, Gan-Or Z, Gagnon JF, Montplaisir JY, Postuma RB.

Parkinsonism Relat Disord. 2018 Apr 4. pii: S1353-8020(18)30155-X. doi: 10.1016/j.parkreldis.2018.04.010. [Epub ahead of print]

PMID:
29724601
4.

Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.

Lipsmeier F, Taylor KI, Kilchenmann T, Wolf D, Scotland A, Schjodt-Eriksen J, Cheng WY, Fernandez-Garcia I, Siebourg-Polster J, Jin L, Soto J, Verselis L, Boess F, Koller M, Grundman M, Monsch AU, Postuma RB, Ghosh A, Kremer T, Czech C, Gossens C, Lindemann M.

Mov Disord. 2018 Apr 27. doi: 10.1002/mds.27376. [Epub ahead of print]

PMID:
29701258
5.

Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorder.

Rahayel S, Postuma RB, Montplaisir J, Génier Marchand D, Escudier F, Gaubert M, Bourgouin PA, Carrier J, Monchi O, Joubert S, Blanc F, Gagnon JF.

Neurology. 2018 May 15;90(20):e1759-e1770. doi: 10.1212/WNL.0000000000005523. Epub 2018 Apr 18.

PMID:
29669906
6.

How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder.

Génier Marchand D, Postuma RB, Escudier F, De Roy J, Pelletier A, Montplaisir J, Gagnon JF.

Ann Neurol. 2018 Apr 17. doi: 10.1002/ana.25239. [Epub ahead of print]

PMID:
29665124
7.

Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts.

Dawson BK, Fereshtehnejad SM, Anang JBM, Nomura T, Rios-Romenets S, Nakashima K, Gagnon JF, Postuma RB.

JAMA Neurol. 2018 Jun 1;75(6):704-710. doi: 10.1001/jamaneurol.2018.0254.

PMID:
29582054
8.

LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder.

Ouled Amar Bencheikh B, Ruskey JA, Arnulf I, Dauvilliers Y, Monaca CC, De Cock VC, Gagnon JF, Spiegelman D, Hu MTM, Högl B, Stefani A, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Mollenhauer B, Sixel-Döring F, Trenkwalder C, Oertel W, Montplaisir JY, Postuma RB, Rouleau GA, Gan-Or Z.

Parkinsonism Relat Disord. 2018 Mar 21. pii: S1353-8020(18)30134-2. doi: 10.1016/j.parkreldis.2018.03.019. [Epub ahead of print]

PMID:
29576439
9.

Sleep disorders and Parkinson disease; lessons from genetics.

Gan-Or Z, Alcalay RN, Rouleau GA, Postuma RB.

Sleep Med Rev. 2018 Jan 31. pii: S1087-0792(18)30007-8. doi: 10.1016/j.smrv.2018.01.006. [Epub ahead of print] Review.

PMID:
29449121
10.

Prospective memory in idiopathic REM sleep behavior disorder with or without mild cognitive impairment: a preliminary study.

Marcone S, Gagnon JF, Desjardins C, David AC, Postuma RB, Montplaisir J, Joubert S, Rouleau I.

Clin Neuropsychol. 2018 Feb 7:1-23. doi: 10.1080/13854046.2018.1435825. [Epub ahead of print]

PMID:
29411691
11.

A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging.

Zeighami Y, Fereshtehnejad SM, Dadar M, Collins DL, Postuma RB, Mišić B, Dagher A.

Neuroimage. 2017 Dec 19. pii: S1053-8119(17)31074-1. doi: 10.1016/j.neuroimage.2017.12.050. [Epub ahead of print] Review.

PMID:
29277406
12.

Domperidone for Hypotension in Parkinson's Disease: A Systematic Review.

Bacchi S, Chim I, Kramer P, Postuma RB.

J Parkinsons Dis. 2017;7(4):603-617. doi: 10.3233/JPD-171209. Review.

PMID:
29103053
13.

Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.

Darweesh SKL, Wolters FJ, Postuma RB, Stricker BH, Hofman A, Koudstaal PJ, Ikram MK, Ikram MA.

JAMA Neurol. 2017 Dec 1;74(12):1431-1438. doi: 10.1001/jamaneurol.2017.2248.

PMID:
28973176
14.

Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial.

Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE.

Neurology. 2017 Oct 24;89(17):1795-1803. doi: 10.1212/WNL.0000000000004568. Epub 2017 Sep 27.

PMID:
28954882
15.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

PMID:
28887905
16.

Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson's Disease.

Law C, Chriqui E, Kergoat MJ, Leclerc BS, Panisset M, Irving EL, Postuma RB, Chouinard S, Kergoat H.

Can J Neurol Sci. 2017 Sep;44(5):562-566. doi: 10.1017/cjn.2017.39.

PMID:
28862105
17.

Nonmotor Aspects of Parkinson's Disease-How Do They Help Diagnosis?

Postuma RB.

Int Rev Neurobiol. 2017;133:519-539. doi: 10.1016/bs.irn.2017.04.002. Epub 2017 Jun 7. Review.

PMID:
28802931
18.

Dementia with Lewy bodies: Diagnosis is only skin deep?

Postuma RB, Walker Z.

Neurology. 2017 Jul 25;89(4):310-311. doi: 10.1212/WNL.0000000000004163. Epub 2017 Jun 30. No abstract available.

PMID:
28667177
19.

Insomnia and somnolence in idiopathic RBD: a prospective cohort study.

Postuma RB, Gagnon JF, Pelletier A, Montplaisir JY.

NPJ Parkinsons Dis. 2017 Mar 20;3:9. doi: 10.1038/s41531-017-0011-7. eCollection 2017.

20.

Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.

Shafieesabet A, Fereshtehnejad SM, Shafieesabet A, Delbari A, Baradaran HR, Postuma RB, Lökk J.

Parkinsonism Relat Disord. 2017 Sep;42:1-11. doi: 10.1016/j.parkreldis.2017.06.006. Epub 2017 Jun 15. Review.

PMID:
28647434
21.

REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson's Disease.

Jozwiak N, Postuma RB, Montplaisir J, Latreille V, Panisset M, Chouinard S, Bourgouin PA, Gagnon JF.

Sleep. 2017 Aug 1;40(8). doi: 10.1093/sleep/zsx101.

PMID:
28645156
22.

Dopaminergic Imaging and Prodromal Parkinson Disease: A Key Biomarker Arrives.

Postuma RB.

JAMA Neurol. 2017 Aug 1;74(8):901-903. doi: 10.1001/jamaneurol.2017.0846. No abstract available.

PMID:
28595262
23.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

24.

Abnormal Gray Matter Shape, Thickness, and Volume in the Motor Cortico-Subcortical Loop in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Association with Clinical and Motor Features.

Rahayel S, Postuma RB, Montplaisir J, Bedetti C, Brambati S, Carrier J, Monchi O, Bourgouin PA, Gaubert M, Gagnon JF.

Cereb Cortex. 2018 Feb 1;28(2):658-671. doi: 10.1093/cercor/bhx137.

PMID:
28591814
25.

The New Diagnostic Criteria for Parkinson's Disease.

Postuma RB, Berg D.

Int Rev Neurobiol. 2017;132:55-78. doi: 10.1016/bs.irn.2017.01.008. Epub 2017 Mar 3. Review.

PMID:
28554421
26.

Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.

Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB.

Brain. 2017 Jul 1;140(7):1959-1976. doi: 10.1093/brain/awx118.

PMID:
28549077
27.

Sleep Disorders and RBD: What Would James Parkinson Think?

Postuma RB.

Mov Disord. 2017 May;32(5):705-707. doi: 10.1002/mds.27030. No abstract available.

PMID:
28513080
28.

Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.

Pilotto A, Heinzel S, Suenkel U, Lerche S, Brockmann K, Roeben B, Schaeffer E, Wurster I, Yilmaz R, Liepelt-Scarfone I, von Thaler AK, Metzger FG, Eschweiler GW, Postuma RB, Maetzler W, Berg D.

Mov Disord. 2017 Jul;32(7):1025-1034. doi: 10.1002/mds.27035. Epub 2017 May 16.

PMID:
28509336
29.

Sleep Disturbances in the Prodromal Stage of Parkinson Disease.

Al-Qassabi A, Fereshtehnejad SM, Postuma RB.

Curr Treat Options Neurol. 2017 Jun;19(6):22. doi: 10.1007/s11940-017-0458-1. Review.

PMID:
28466429
30.

Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.

Fereshtehnejad SM, Montplaisir JY, Pelletier A, Gagnon JF, Berg D, Postuma RB.

Mov Disord. 2017 Jun;32(6):865-873. doi: 10.1002/mds.26989. Epub 2017 Apr 21.

PMID:
28429825
31.

Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder.

Gan-Or Z, Ruskey JA, Spiegelman D, Arnulf I, Dauvilliers Y, Högl B, Monaca-Charley C, Postuma RB, Montplaisir JY, Rouleau GA.

Brain. 2017 Jun 1;140(6):e32. doi: 10.1093/brain/awx076. No abstract available.

PMID:
28379291
32.

Detecting the Cognitive Prodrome of Dementia with Lewy Bodies: A Prospective Study of REM Sleep Behavior Disorder.

Génier Marchand D, Montplaisir J, Postuma RB, Rahayel S, Gagnon JF.

Sleep. 2017 Jan 1;40(1). doi: 10.1093/sleep/zsw014.

PMID:
28364450
33.

Neurodegeneration in REM sleep behavior disorder: Stratification keeps improving.

Postuma RB, Trenkwalder C.

Neurology. 2017 Apr 18;88(16):1486-1487. doi: 10.1212/WNL.0000000000003850. Epub 2017 Mar 22. No abstract available.

PMID:
28330957
34.

Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?

Fereshtehnejad SM, Postuma RB.

Curr Neurol Neurosci Rep. 2017 Apr;17(4):34. doi: 10.1007/s11910-017-0738-x. Review.

PMID:
28324303
35.

Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk?

Arnaldi D, Antelmi E, St Louis EK, Postuma RB, Arnulf I.

Sleep Med Rev. 2017 Dec;36:82-95. doi: 10.1016/j.smrv.2016.11.002. Epub 2016 Nov 10. Review.

PMID:
28082168
36.

Dementia Predictors in Parkinson Disease: A Validation Study.

Anang JB, Nomura T, Romenets SR, Nakashima K, Gagnon JF, Postuma RB.

J Parkinsons Dis. 2017;7(1):159-162. doi: 10.3233/JPD-160925.

PMID:
27911340
37.

The dementia-associated APOE ε4 allele is not associated with rapid eye movement sleep behavior disorder.

Gan-Or Z, Montplaisir JY, Ross JP, Poirier J, Warby SC, Arnulf I, Strong S, Dauvilliers Y, Leblond CS, Hu MTM, Högl B, Stefani A, Monaca CC, De Cock VC, Boivin M, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Barber TR, Evetts SG, Rolinski M, Dion PA, Desautels A, Gagnon JF, Dupré N, Postuma RB, Rouleau GA.

Neurobiol Aging. 2017 Jan;49:218.e13-218.e15. doi: 10.1016/j.neurobiolaging.2016.10.002. Epub 2016 Oct 13.

PMID:
27814994
38.

Large-scale population screening for prodromal PD: a way forward becomes clear.

Postuma RB, Montplaisir JY.

Sleep Med. 2016 Aug;24:148. doi: 10.1016/j.sleep.2016.07.004. Epub 2016 Jul 25. No abstract available.

PMID:
27568526
39.

Genome-wide association study in essential tremor identifies three new loci.

Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G, Rouleau GA.

Brain. 2016 Dec;139(Pt 12):3163-3169. Epub 2016 Oct 20.

40.

Advances in markers of prodromal Parkinson disease.

Postuma RB, Berg D.

Nat Rev Neurol. 2016 Oct 27;12(11):622-634. doi: 10.1038/nrneurol.2016.152. Review.

PMID:
27786242
41.

Abolishing the 1-year rule: How much evidence will be enough?

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G.

Mov Disord. 2016 Nov;31(11):1623-1627. doi: 10.1002/mds.26796. Epub 2016 Sep 26. No abstract available.

PMID:
27666574
42.

Clinical Utility of the Envelope Task in Mild Cognitive Impairment and Dementia.

Marcone S, Gagnon JF, Lecomte S, Imbeault H, Limoges F, Postuma RB, Bertrand JA, Joubert S, Rouleau I.

Can J Neurol Sci. 2017 Jan;44(1):9-16. doi: 10.1017/cjn.2016.298. Epub 2016 Sep 26.

PMID:
27665668
43.

Resting state MRI: a new marker of prodromal neurodegeneration?

Postuma RB.

Brain. 2016 Aug;139(Pt 8):2106-8. doi: 10.1093/brain/aww131. No abstract available.

PMID:
27457227
44.

Screening for prodromal Parkinson's disease in the general community: a sleep-based approach.

Postuma RB, Pelletier A, Berg D, Gagnon JF, Escudier F, Montplaisir J.

Sleep Med. 2016 May;21:101-5. doi: 10.1016/j.sleep.2015.12.016. Epub 2016 Mar 10.

PMID:
27448479
45.

The new definition and diagnostic criteria of Parkinson's disease.

Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, Olanow CW, Poewe W, Stern M.

Lancet Neurol. 2016 May;15(6):546-8. doi: 10.1016/S1474-4422(16)00116-2. Epub 2016 Apr 11. No abstract available.

PMID:
27302120
46.

Cautionary optimism: caffeine and Parkinson's disease risk.

Sokol LL, Young MJ, Espay AJ, Postuma RB.

J Clin Mov Disord. 2016 Jun 6;3:7. doi: 10.1186/s40734-016-0037-8. eCollection 2016.

47.

The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder.

Gan-Or Z, Mohsin N, Girard SL, Montplaisir JY, Ambalavanan A, Strong S, Mallett V, Laurent SB, Bourassa CV, Boivin M, Langlois M, Arnulf I, Högl B, Frauscher B, Monaca C, Desautels A, Gagnon JF, Postuma RB, Dion PA, Dauvilliers Y, Dupre N, Alcalay RN, Rouleau GA.

Neurobiol Aging. 2016 Jul;43:180.e7-180.e13. doi: 10.1016/j.neurobiolaging.2016.03.029. Epub 2016 Apr 6.

48.

Age, Gender, Comorbidity, and the MDS-UPDRS: Results from a Population-Based Study.

Keezer MR, Wolfson C, Postuma RB.

Neuroepidemiology. 2016;46(3):222-7. doi: 10.1159/000444021. Epub 2016 Mar 12.

PMID:
26967747
49.

Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease.

Latreille V, Carrier J, Gaudet-Fex B, Rodrigues-Brazète J, Panisset M, Chouinard S, Postuma RB, Gagnon JF.

Brain. 2016 Apr;139(Pt 4):1189-99. doi: 10.1093/brain/aww018. Epub 2016 Feb 16.

50.

Diagnosis of Parkinson's disease: Imaging and genetics.

Berg D, Postuma RB.

Mov Disord. 2016 Mar;31(3):431-2. doi: 10.1002/mds.26544. Epub 2016 Feb 22. No abstract available.

PMID:
26898197

Supplemental Content

Loading ...
Support Center